Jeremy Bender's most recent trade in Aura Biosciences Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aura Biosciences Inc | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Aura Biosciences Inc | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2026 | 30,000 | 30,000 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 1,463,134 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 808,285 | 0 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 397,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 355,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 300,000 | 0 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 300,000 | 0 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 286,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 286,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 244,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 222,188 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 204,643 | 0 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 147,702 | 0 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 128,565 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 81,816 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 20,204 | 0 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 18,197 | 0 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Apr 2026 | 14,250 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Mereo Biopharma Grp PLC (ADR) | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 117,533 | 117,533 | - | - | Deferred Restricted Stock Units | |
| Mereo Biopharma Grp PLC (ADR) | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 66,000 | 66,000 | - | - | Share Options (Right to buy) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 11.60 per share. | 15 Feb 2026 | 15,459 | 204,603 | - | 11.6 | 179,338 | Common Stock |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 14,812 | 222,188 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 14,812 | 220,102 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 11,688 | 81,816 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 11,688 | 193,603 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 11,687 | 128,565 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 11,687 | 205,290 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 4,750 | 14,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2026 | 4,750 | 181,915 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 355,000 | 355,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2026 | 237,000 | 237,000 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2025 | 300,000 | 300,000 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2025 | 300,000 | 808,285 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2025 | 300,000 | 300,000 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2025 | 300,000 | 1,108,285 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2025 | 7,225 | 0 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2025 | 7,225 | 7,225 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 15 Nov 2025 | 15,894 | 177,165 | - | 8.9 | 141,690 | Common Stock |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 11,687 | 93,504 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 11,687 | 193,059 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 11,687 | 181,372 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 11,687 | 140,252 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 4,750 | 19,000 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 4,750 | 169,685 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 3,570 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2025 | 3,570 | 164,935 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 1,463,134 | 1,463,134 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 1,463,134 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 397,000 | 397,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 397,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 286,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 286,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Nov 2025 | 244,000 | 0 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2025 | 244,000 | 244,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 6.77 per share. | 15 Aug 2025 | 16,058 | 161,365 | - | 6.8 | 108,666 | Common Stock |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 11,687 | 105,191 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 11,687 | 177,423 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 11,687 | 165,736 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 11,687 | 151,939 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 4,750 | 23,750 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 4,750 | 154,049 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 3,562 | 3,570 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 3,562 | 149,299 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 199,202 | 1,228,868 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 199,202 | 20,204 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 179,417 | 1,408,285 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 179,417 | 18,197 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 148,312 | 14,450 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 148,312 | 955,338 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 74,328 | 1,029,666 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 74,328 | 147,702 | - | 0 | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 15 May 2025 | 13,964 | 145,737 | - | 6.3 | 87,385 | Common Stock |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 159,701 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 148,014 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 163,626 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 11,687 | 116,878 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 4,750 | 136,327 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 4,750 | 28,500 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 3,562 | 131,577 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 3,562 | 7,132 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 12,048 | 128,015 | - | 12.0 | 144,130 | Common Stock |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 128,376 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 140,063 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 128,565 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 175,313 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,750 | 116,689 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,750 | 33,250 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,562 | 111,939 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,562 | 10,694 | - | - | Restricted Stock Unit (RSU) | |
| Mereo Biopharma Grp PLC (ADR) | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 55,000 | 55,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Jeremy Bender | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 16,768 | 16,768 | - | - | Deferred Restricted Stock Units | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 187,000 | 187,000 | - | - | Restricted Stock Units | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 11,687 | 118,931 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 11,687 | 140,252 | - | - | Restricted Stock Unit (RSU) | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 10,554 | 108,377 | - | 13.2 | 139,420 | Common Stock |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 4,750 | 107,244 | - | - | Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 4,750 | 38,000 | - | - | Restricted Stock Unit (RSU) |